Clinical trial data from a multi-national, double-blinded trial of FT011 being developed for the treatment of systemic sclerosis (scleroderma) presented at the American College of Rheumatology Annual ...
Early intervention in patients with SSc can help modify disease progression prior to the occurrence of irreversible organ damage.
University of Virginia School of Medicine researchers have uncovered a possible way to prevent the dangerous hardening of skin and organs in people with systemic scleroderma, a rare autoimmune disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results